{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-089549","form_type":"8-K","ticker":"TRDA","cik":"0001689375","company_name":"Entrada Therapeutics, Inc.","filed_at":"2023-08-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:34.861680+00:00","generated_at":"2026-06-11T18:14:36.017442+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Entrada Therapeutics appoints Gina Chapman to board effective Sept 1, 2023","bullets":["Gina Chapman, President and CEO of CARGO Therapeutics, joins as Class III director.","Effective Sept 1, 2023; also appointed to Nominating and Corporate Governance Committee.","Initial equity grant of $500K value (32,000 shares of common stock) vesting over 3 years.","Annual director fee of $40,000 plus $4,000 for committee service; standard indemnification."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-089549","json":"https://secwatch.observer/filing/0001104659-23-089549.json","markdown":"https://secwatch.observer/filing/0001104659-23-089549.md","text":"https://secwatch.observer/filing/0001104659-23-089549.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1689375/000110465923089549/0001104659-23-089549-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1689375/000110465923089549/tm2323293d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-11T18:14:36.017442+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"d0aff4ef5d","claim":"Gina Chapman was appointed as Class III director at Entrada Therapeutics, Inc..","evidence_excerpt":"On August 4, 2023, the Board of Directors (the “Board”) of Entrada Therapeutics, Inc. (the “Company”) appointed Gina Chapman to the Board as a Class III director, effective September 1, 2023","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1689375/000110465923089549/0001104659-23-089549-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Class III director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}